Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Canada Research Roundup: Aurora Cannabis, Cathedral Energy Services, Teck Resources

Sept 22 (Reuters) - Securities analysts revised their ratings and price targets on
several Canadian companies, including Aurora Cannabis, Cathedral Energy Services and Teck
Resources, on Thursday. 
    HIGHLIGHTS    
     * Aurora Cannabis  ACB.TO : Atb Capital Markets raises to sector perform from underperform
     * Cathedral Energy Services  CET.TO : Stifel FirstEnergy initiates with buy rating; PT C$1.65
     * Teck Resources Ltd  TECKb.TO : CIBC cuts target price to C$56.5 from C$58
 Following is a summary of research actions on Canadian companies reported by Reuters on
Thursday. Stock entries are in alphabetical order. 
     * Aurora Cannabis  ACB.TO : Atb Capital Markets raises to sector perform from underperform
     * Aurora Cannabis  ACB.TO : Atb Capital Markets cuts target price to C$2 from C$3
     * Aurora Cannabis Inc  ACB.TO : CIBC cuts target price to C$2.25 from C$2.5
     * Badger Infrastructure Solutions Ltd  BDGI.TO : Scotiabank raises PT to C$38.5 from C$38
     * Canadian National Railway Co  CNR.TO : National Bank of Canada ups PT to C$173 from C$166
     * Canadian Pacific Railway Ltd  CP.TO : National Bank of Canada raises PT to C$105 from C$98
     * Cathedral Energy Services  CET.TO : Stifel FirstEnergy initiates with buy rating; PT C$1.65
     * K92 Mining Inc  KNT.TO : Haywood Securities raises target price to C$11 from C$10
     * Medexus Pharmaceuticals  MDP.TO : Canaccord Genuity cuts target to C$2.75 from C$3.5
     * MCAN Mortgage  MKP.TO : Canaccord Genuity initiates coverage with buy rating; PT C$18.25
     * Park Lawn Corp  PLC.TO : RBC cuts target price to C$44 from C$49
     * Teck Resources Ltd  TECKb.TO : CIBC cuts target price to C$56.5 from C$58
     * Trilogy Metals Inc  TMQ.TO : TD Securities cuts target price to C$1.15 from C$1.3
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Medexus Pharmaceuticals

See all news